Drug profile · INN
nimodipine
NIMODIPINE
nimodipine (NIMODIPINE) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Drug details — nimodipine
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 1
- Programs
- 1
- Data quality
- 0.84
Quick answer
nimodipine (NIMODIPINE) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Mineralocorticoid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
Frequently asked questions
What is nimodipine?
nimodipine (NIMODIPINE) is a voltage-gated l-type calcium channel blocker. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for nimodipine?
NIMODIPINE is a marketed brand name for nimodipine. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of nimodipine?
nimodipine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.